PROSPECT(TM/CRYPTOSPORIDIUM— 510(k) K912242

Substantially Equivalent

Alexon, Inc.

FDA 510(k) clearance K912242 for PROSPECT(TM/CRYPTOSPORIDIUM, Substantially Equivalent on 1992-03-23. Applicant: Alexon, Inc..

Clearance details

Applicant
Alexon, Inc.
Product code
Code MHJ
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mountain View, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.